Bamlanivimab + Etesevimab

Bamlanivimab+Etesevimab is used in the treatment of Coronavirus disease (COVID-19). mild to moderate.

Bamlanivimab + Etesevimab is a combination of two human immunoglobulin G-1 (IgG1) neutralizing monoclonal antibodies that bind at different sites on the spike protein of SARS-CoV-2, the virus that causes Covid-19. This unique binding mechanism, developed using recombinant DNA technology, is equally effective against the existing as well as newer emerging variants in preventing the virus from attaching to the human cell receptors.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them